BCHE and Alzheimer disease: Consequently, antagonists to the N-methyl-D-aspartate (NMDA) glutamatergic receptor, such as memantine (Nemenda), are used in conjunction with cholinesterase inhibitors to support memory in patients with mild to moderate AD [255, 256].